Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32150
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wu, N | - |
dc.contributor.author | Phelps, A | - |
dc.contributor.author | Bhuiya, AR | - |
dc.contributor.author | Sivanesanathan, T | - |
dc.contributor.author | Dass, R | - |
dc.contributor.author | Whitelaw, H | - |
dc.contributor.author | Wang, Q | - |
dc.contributor.author | Wilson, MG | - |
dc.date.accessioned | 2025-08-14T17:55:34Z | - |
dc.date.available | 2025-08-14T17:55:34Z | - |
dc.date.issued | 2025-03 | - |
dc.identifier.citation | Wu N, Phelps A, Bhuiya AR, Sivanesanathan T, Dass R, Whitelaw H, Wang Q, Wilson MG. Rapid evidence synthesis 127. Efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants. Hamilton: McMaster Health Forum, 7 March 2025. | en_US |
dc.identifier.issn | 2819-5639 | - |
dc.identifier.uri | http://hdl.handle.net/11375/32150 | - |
dc.description.abstract | An in-depth synthesis of what is known based on the best available global research evidence (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about the efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants in response to a decision-maker's request. | en_US |
dc.description.sponsorship | This rapid evidence synthesis was commissioned and funded by the Office of the Chief Science Officer, Public Health Agency of Canada. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | RES 127; | - |
dc.subject | respiratory | en_US |
dc.subject | syncytial virus | en_US |
dc.subject | vaccines | en_US |
dc.subject | antibodies | en_US |
dc.subject | disease | en_US |
dc.subject | older adults | en_US |
dc.subject | infants | en_US |
dc.title | Rapid evidence synthesis 127: Efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants | en_US |
Appears in Collections: | Rapid evidence synthesis |
Files in This Item:
This item is licensed under a Creative Commons License